Search Results - "Bove, J R"

Effect of hyperosmolality on control of blood flow and sweating by Fortney, S M, Wenger, C B, Bove, J R, Nadel, E R

“…To study the effect of hyperosmolality on thermoregulatory responses, five men [average maximal O2 consumption (VO2 max) = 48 ml X kg-1 X min-1] cycled at…”
Get more information

Effect of blood volume on sweating rate and body fluids in exercising humans by Fortney, S M, Nadel, E R, Wenger, C B, Bove, J R

“…Five relatively fit men performed cycle ergometer exercise (65-70% VO2max) for up to 30 min at 30 degrees C, 40% rh. The data from control (normo-volemic),…”
Get more information

Testing in the years ahead: new pressures and new concerns by Bove, J R

“…In the past, testing by blood banks was intended primarily to ensure product quality or donor safety or to meet existing regulations. As a result of recent…”
Get more information

Blood donation and transfusion practices: the 1990 American Association of Blood Banks Institutional Membership Questionnaire by Devine, P, Postoway, N, Hoffstadter, L, Surgenor, D M, Linden, J V, Hines, D, Chernoff, A, Ciavarella, D, Bove, J R

“…Responses to the 1990 American Association of Blood Banks (AABB) Institutional Membership Questionnaire were submitted by 2126 regional blood centers,…”
Get more information

Effect of acute alterations of blood volume on circulatory performance in humans by Fortney, S M, Nadel, E R, Wenger, C B, Bove, J R

“…Six subjects exercised (60% VO2 max) in a 35 degree C environment on the day prior to (C1) and 1 h after withdrawal (PW) of 10% of each subject's blood volume,…”
Get more information

Effect of blood volume on forearm venous and cardiac stroke volume during exercise by Fortney, S M, Wenger, C B, Bove, J R, Nadel, E R

“…Five healthy men exercised at 65-70% of maximum O2 uptake (VO2 max) for 30 min in an ambient temperature of 30 degrees C. Duplicate experiments were conducted…”
Get more information

A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitis by Zuck, T F, Sherwood, W C, Bove, J R

“…A workshop sponsored by the Food and Drug Administration was held recently during which available data were reviewed concerning surrogate testing of blood…”
Get more information

Transfusion-transmitted diseases: current problems and challenges by Bove, J R

Get more information

Transfusion-associated hepatitis and AIDS. What is the risk? by Bove, J R

“…Infectious complications have been, and will continue to be, a problem in recipients of blood transfusions. Steps to exclude high-risk donors and to test for…”
Get more information

Chemical and hematologic changes in stored CPDA-1 blood by Latham, Jr, J T, Bove, J R, Weirich, F L

“…Blood was drawn from ten healthy volunteer donors into citrate-phosphate-dextrose adenine (CPDA-1) anticoagulant and placed on the quarantine shelf of the…”
Get more information

The effect of storage on the ganglioside content of human platelets by Koerner, T A, Weinfeld, H M, Yu, R K, Bove, J R

“…Gangliosides are glycolipids which contain sialic acid and are found in the membranes of mammalian cells. By analogy with recent studies of other cells, it is…”
Get more information

Results of nationwide screening of blood and plasma for antibodies to human T-cell lymphotrophic III virus, type III by Kuritsky, J N, Rastogi, S C, Faich, G A, Schorr, J B, Menitove, J E, Reilly, R W, Bove, J R

“…From April 22 to July 28, and from October 7 to November 3, 1985 the American Red Cross, the Council of Community Blood Centers, the American Association of…”
Get more information

Transfusion-transmitted diseases other than AIDS and hepatitis by Bove, J R

“…Although the major diseases transmitted by transfusion today are AIDS and hepatitis, many others also are known. These include CMV, syphilis, Chagas disease,…”
Get full text

Fresh frozen plasma: too few indications--too much use by Bove, J R

Get full text

Fibrinogen--is the benefit worth the risk? by Bove, J R

Get more information

Gene expression analysis by cDNA-AFLP highlights a set of new signaling networks and translational control during seed dormancy breaking in Nicotiana plumbaginifolia by Bove, J, Lucas, P, Godin, B, Oge, L, Jullien, M, Grappin, P

“…Seed dormancy in Nicotiana plumbaginifolia is characterized by an abscisic acid accumulation linked to a pronounced germination delay. Dormancy can be released…”
Get full text

Low titer blood by Bove, J R

Get more information

Anti-HTLV-III/LAV in pooled sera by Bove, J R, DePalma, L, Weirich, F

Get more information

Epidemiological studies with anti-hepatitis C virus by Bove, J R

Get more information

Look-back: preliminary experience of AABB members. American Association of Blood Banks by Bove, J R, Rigney, P R, Kehoe, P M, Campbell, J

“…By mid-fall of 1986 the "look-back" process conducted by blood banks belonging to the American Association of Blood Banks was about 50 percent complete. Over…”
Get more information